作者: Gregory J. Riely , Mark G. Kris , Daniel Rosenbaum , Jenifer Marks , Allan Li
DOI: 10.1158/1078-0432.CCR-08-0646
关键词: Adenocarcinoma 、 Cancer 、 Lung cancer 、 Mutation 、 Medicine 、 Oncology 、 Erlotinib 、 Internal medicine 、 KRAS 、 Gefitinib 、 Pathology 、 Confidence interval
摘要: … which tumors have KRAS mutations by any clinical characteristics. Based on these data, we … interest in the molecular basis of lung cancer in patients who never smoked cigarettes (1–3). …